CN102772508B - 一种治疗仔猪白痢的中药复方连翁止痢散及其制备方法和应用 - Google Patents
一种治疗仔猪白痢的中药复方连翁止痢散及其制备方法和应用 Download PDFInfo
- Publication number
- CN102772508B CN102772508B CN201210289442.3A CN201210289442A CN102772508B CN 102772508 B CN102772508 B CN 102772508B CN 201210289442 A CN201210289442 A CN 201210289442A CN 102772508 B CN102772508 B CN 102772508B
- Authority
- CN
- China
- Prior art keywords
- solution
- preparation
- powder
- chinese medicine
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 64
- 239000003814 drug Substances 0.000 title claims abstract description 51
- 239000000843 powder Substances 0.000 title claims abstract description 39
- 150000001875 compounds Chemical class 0.000 title abstract description 8
- 239000000463 material Substances 0.000 claims abstract description 53
- 239000009806 pulsatillae Substances 0.000 claims abstract description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000012360 testing method Methods 0.000 claims description 81
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 72
- 239000000523 sample Substances 0.000 claims description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 54
- 239000013642 negative control Substances 0.000 claims description 48
- 239000002904 solvent Substances 0.000 claims description 48
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 40
- 239000000047 product Substances 0.000 claims description 40
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 28
- 239000012567 medical material Substances 0.000 claims description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 25
- 239000003208 petroleum Substances 0.000 claims description 18
- 239000013558 reference substance Substances 0.000 claims description 18
- 239000000741 silica gel Substances 0.000 claims description 17
- 229910002027 silica gel Inorganic materials 0.000 claims description 17
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 claims description 15
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 14
- 239000007921 spray Substances 0.000 claims description 14
- 230000008034 disappearance Effects 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 12
- DMCLHHBLEQZLOC-ARLBSWEISA-N [(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1r,3as,5ar,5br,7ar,8r,9s,11ar,11br,13ar,13br)-8-(hydroxymethyl)-5a,5b,8,11a-t Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](OC(=O)[C@@]34[C@H]([C@@H](CC3)C(C)=C)[C@@H]3[C@@]([C@]5(C)CC[C@H]6[C@](C)(CO)[C@@H](O[C@H]7[C@@H]([C@@H](O)[C@@H](O)CO7)O)CC[C@]6(C)[C@H]5CC3)(C)CC4)O2)O)[C@H](O)[C@H]1O DMCLHHBLEQZLOC-ARLBSWEISA-N 0.000 claims description 12
- OUHBKBTZUPLIIA-UHFFFAOYSA-N pulchinenoside B Natural products OC1C(O)C(O)C(C)OC1OC1C(CO)OC(OCC2C(C(O)C(O)C(OC(=O)C34C(C(CC3)C(C)=C)C3C(C5(C)CCC6C(C)(CO)C(OC7C(C(O)C(O)CO7)OC7C(C(O)C(O)C(C)O7)O)CCC6(C)C5CC3)(C)CC4)O2)O)C(O)C1O OUHBKBTZUPLIIA-UHFFFAOYSA-N 0.000 claims description 12
- 238000000605 extraction Methods 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 7
- 238000002137 ultrasound extraction Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- VKJGBAJNNALVAV-UHFFFAOYSA-M Berberine chloride (TN) Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 VKJGBAJNNALVAV-UHFFFAOYSA-M 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 5
- 241000588724 Escherichia coli Species 0.000 abstract description 4
- 230000029087 digestion Effects 0.000 abstract description 4
- 238000012216 screening Methods 0.000 abstract description 4
- 238000000227 grinding Methods 0.000 abstract description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000003610 charcoal Substances 0.000 abstract description 2
- 239000000835 fiber Substances 0.000 abstract description 2
- 239000002245 particle Substances 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 241001166194 Geranium wilfordii Species 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 208000001848 dysentery Diseases 0.000 description 45
- 241000282898 Sus scrofa Species 0.000 description 16
- 238000000079 presaturation Methods 0.000 description 14
- 238000011835 investigation Methods 0.000 description 13
- 238000010298 pulverizing process Methods 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000004809 thin layer chromatography Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 238000007445 Chromatographic isolation Methods 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 208000006650 Overbite Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000007689 inspection Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 238000012850 discrimination method Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010052804 Drug tolerance Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000446313 Lamella Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 244000144987 brood Species 0.000 description 3
- 230000007012 clinical effect Effects 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 101710146739 Enterotoxin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 239000000147 enterotoxin Substances 0.000 description 2
- 231100000655 enterotoxin Toxicity 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229960001471 sodium selenite Drugs 0.000 description 2
- 235000015921 sodium selenite Nutrition 0.000 description 2
- 239000011781 sodium selenite Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012938 design process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 231100000567 intoxicating Toxicity 0.000 description 1
- 230000002673 intoxicating effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000019989 milk ejection Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- -1 sieve Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210289442.3A CN102772508B (zh) | 2012-08-15 | 2012-08-15 | 一种治疗仔猪白痢的中药复方连翁止痢散及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210289442.3A CN102772508B (zh) | 2012-08-15 | 2012-08-15 | 一种治疗仔猪白痢的中药复方连翁止痢散及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102772508A CN102772508A (zh) | 2012-11-14 |
CN102772508B true CN102772508B (zh) | 2014-04-09 |
Family
ID=47117765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210289442.3A Expired - Fee Related CN102772508B (zh) | 2012-08-15 | 2012-08-15 | 一种治疗仔猪白痢的中药复方连翁止痢散及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102772508B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102293860A (zh) * | 2011-09-05 | 2011-12-28 | 高朱荣 | 一种治疗腹泻的中药 |
-
2012
- 2012-08-15 CN CN201210289442.3A patent/CN102772508B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102293860A (zh) * | 2011-09-05 | 2011-12-28 | 高朱荣 | 一种治疗腹泻的中药 |
Non-Patent Citations (2)
Title |
---|
李新实.老鹳草汤治疗痢疾.《山东中医杂志》.1997,第16卷(第10期),第440页. |
老鹳草汤治疗痢疾;李新实;《山东中医杂志》;19971031;第16卷(第10期);第440页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102772508A (zh) | 2012-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pu et al. | Research progress in the application of Chinese herbal medicines in aquaculture: a review | |
CN112274620B (zh) | 治疗新型冠状病毒肺炎的中药组合物、制备方法、检测方法及其用途 | |
Li et al. | The anti-hyperglycemic effect of plants in genus Gynura Cass. | |
CN102274314A (zh) | 常青球虫散及其制备方法 | |
CN106667915A (zh) | 一种用于治疗仔猪腹泻的黄芩苷铝干混悬剂 | |
CN101433641A (zh) | 一种口服中药组合物及其制备、服用、质量检查方法和用途 | |
CN110960594A (zh) | 一种治疗腹泻型肠易激综合征的中药组合物 | |
CN102861122B (zh) | 一种兽用北芪五加颗粒的制备工艺 | |
CN111407783A (zh) | 赶黄草在制备治疗高蛋白尿药物中的应用 | |
CN102764314B (zh) | 一种治疗仔猪白痢的中药复方连翁止痢颗粒及其制备方法和应用 | |
CN103127198B (zh) | 治疗仔猪黄白痢的联合用药物 | |
WO2005074952A1 (fr) | Medicament chinois pour le traitement du syndrome du colon irritable ainsi que preparation de celui-ci | |
CN104256165A (zh) | 用于防治慢性型猪瘟疫的功能性饲料及其制备方法 | |
CN111568949A (zh) | 桑提取物在制备调节动物肠道菌群的药物中的用途 | |
CN102772508B (zh) | 一种治疗仔猪白痢的中药复方连翁止痢散及其制备方法和应用 | |
CN106361830A (zh) | 一种大黄末及其制备方法 | |
CN107412354B (zh) | 一种兽用枫蓼颗粒剂及其在鸡坏死性肠炎中的应用 | |
CN105343229A (zh) | 一种防治畜禽大肠杆菌病的中药组合物及其制备方法 | |
CN102499322B (zh) | 具有促进记忆改善的保健类食品或药品 | |
CN114949070A (zh) | 鹿茸草有效部位提取物在制备治疗炎性疾病或肿瘤药物中的应用 | |
CN101396427A (zh) | 一种用于治疗家禽病毒性肝炎及肝损伤的中药口服液 | |
CN111588801A (zh) | 一种预防畜禽疫病的中药分散颗粒剂及其制备方法 | |
CN104491418A (zh) | 一种治疗溃疡性结肠炎的中药制剂 | |
CN106588827B (zh) | 用于治疗溃疡性结肠炎的金丝海棠提取物的提取方法及应用 | |
CN1243443A (zh) | 用于增殖双歧杆菌的鲜地黄提取物及其提取方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: QINGDAO KDN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: QINGDAO AGRICULTURAL UNIVERSITY Effective date: 20131108 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhong Yingjie Inventor after: Fu Haining Inventor after: Pang Yunlu Inventor after: Wang Yanling Inventor before: Hao Zhihui Inventor before: Zhong Yingjie Inventor before: Wang Chunyuan Inventor before: Fu Haining Inventor before: Pang Yunlu Inventor before: Jia Deqiang Inventor before: Shen Wei Inventor before: Wang Yanling |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HAO ZHIHUI ZHONG YINGJIE WANG CHUNYUAN FU HAINING PANG YUNLU JIA DEQIANG SHEN WEI WANG YANLING TO: ZHONG YINGJIE FU HAINING PANG YUNLU WANG YANLING Free format text: CORRECT: ADDRESS; FROM: 266109 QINGDAO, SHANDONG PROVINCE TO: 266111 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20131108 Address after: Dual northbound Chengyang District 266111 in Shandong Province, Qingdao City, the first Green Industrial Park continet Animal Pharmaceutical Co. Ltd. is a R & D center building Applicant after: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Applicant after: QINGDAO KDN BIOTECH Co.,Ltd. Address before: 266109 Qingdao Road, Chengyang District, Shandong, No. 700 the Great Wall Applicant before: Qingdao Agricultural University Applicant before: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Applicant before: QINGDAO KDN BIOTECH Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 266061 Shandong province hi tech park of Laoshan Mountain district by the Shandong Road No. 29 building 12F high speed Applicant after: QINGDAO VLAND BIOTECH Inc. Applicant after: QINGDAO KDN BIOTECH Co.,Ltd. Address before: Dual northbound Chengyang District 266111 in Shandong Province, Qingdao City, the first Green Industrial Park continet Animal Pharmaceutical Co. Ltd. is a R & D center building Applicant before: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Applicant before: QINGDAO KDN BIOTECH Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: QINGDAO KDN PHARMACEUTICAL CO., LTD. TO: QINGDAO WEILAN BIOLOGY CO., LTD. |
|
ASS | Succession or assignment of patent right |
Owner name: QINGDAO AGRICULTURAL UNIVERSITY Free format text: FORMER OWNER: QINGDAO WEILAN BIOLOGY CO., LTD. Effective date: 20140307 Owner name: QINGDAO WEILAN BIOLOGY CO., LTD. QINGDAO KDN ANIMA Free format text: FORMER OWNER: QINGDAO KDN ANIMAL PHARMACEUTICAL CO., LTD. Effective date: 20140307 |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Hao Zhihui Inventor after: Zhong Yingjie Inventor after: Wang Chunyuan Inventor after: Fu Haining Inventor after: Pang Yunlu Inventor after: Jia Deqiang Inventor after: Shen Wei Inventor after: Wang Yanling Inventor before: Zhong Yingjie Inventor before: Fu Haining Inventor before: Pang Yunlu Inventor before: Wang Yanling |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHONG YINGJIE FU HAINING PANG YUNLU WANG YANLING TO: HAO ZHIHUI ZHONG YINGJIE WANG CHUNYUAN FU HAINING PANG YUNLU JIA DEQIANG SHEN WEI WANG YANLING Free format text: CORRECT: ADDRESS; FROM: 266061 QINGDAO, SHANDONG PROVINCE TO: 266109 QINGDAO, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140307 Address after: 266109 Qingdao Road, Chengyang District, Shandong, No. 700 the Great Wall Applicant after: Qingdao Agricultural University Applicant after: QINGDAO VLAND BIOTECH Inc. Applicant after: QINGDAO KDN BIOTECH Co.,Ltd. Address before: 266061 Shandong province hi tech park of Laoshan Mountain district by the Shandong Road No. 29 building 12F high speed Applicant before: QINGDAO VLAND BIOTECH Inc. Applicant before: QINGDAO KDN BIOTECH Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140409 |
|
CF01 | Termination of patent right due to non-payment of annual fee |